Abstract: A transmitting and receiving electrode system, and power transmission method using the same are provided. The transmitting and receiving electrode system includes: a voltage/current detection unit measuring a voltage and a current in real time while power is being transmitted between first and second electrodes; a controller calculating a variable element value based on the voltage and current values transferred from the voltage/current detection unit; and a variable element unit converting a variable element under the control of the controller to adjust an impedance of a power source.

Abstract: The present invention provides sulfonated poly(phenylene sulfide sulfone nitrile) and a polymer electrolyte membrane thereof. In particular, the present invention provides sulfonated poly(phenylene sulfide sulfone nitrile) having a triple bond at its both ends and a polymer electrolyte membrane with superior mechanical properties prepared by heating sulfonated poly(phenylene sulfide sulfone nitrile) and forming cross-links between ends of sulfonated poly(phenylene sulfide sulfone nitrile).

Abstract: A method of manufacturing a polyvinylidene fluoride (PVDF)-based polymer film includes: applying a solution formed by dissolving a PVDF-based polymer in a solvent, on a first substrate; forming a PVDF-based polymer film by evaporating the solvent; bonding a support film on the PVDF-based polymer film; weakening an adhesive force between the PVDF-based polymer film and the first substrate; and separating the first substrate from the PVDF-based polymer film.

Abstract: Provided are a pharmaceutical use of poly-gamma-glutamic acid used for preventing or treating Th17-mediated diseases, a composition for preventing or treating Th17-mediated diseases comprising poly-gamma-glutamic acid as an active ingredient, and a method of preventing or treating Th17-mediated diseases using the same. The pharmaceutical composition is effective in inhibiting the differentiation of Th17 cells while promoting Treg cells, and, thus, can be useful in preventing or treating Th17-mediated diseases such as multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, Crohn's disease, ankylosing spondylitis, and the like.

Abstract: A network (100) includes a hub device (110) and at least one unattached peripheral device (120). The hub device comprises circuitry and a transceiver in communication with the circuitry. In operation, the hub device is configured to cause the transceiver to i) send a message to indicate the availability of the hub device for attachment to a first peripheral device, ii) receive, from the first peripheral device, a message indicating the availability of the first peripheral device for communication with the hub device, iii) send, to the first peripheral device, a signal including a first peripheral device identifier, iv) receive, from the first peripheral device, a response, v) send a hub response to the first peripheral device, and vi) receive, from the first peripheral device, a second peripheral response including the first peripheral device identifier.

Abstract: A peripheral device comprises a first entity and a second entity. In operation, the first/second entities are configured to respectively: receive a first/second entity-related message from at least one other device to indicate the availability of the at least one other device for attachment, send, to the at least one other device, a first/second entity-related message indicating the availability for communication with the at least one other device, receive, from the at least one other device, a first/second entity-related signal including a first/second entity-related peripheral device identifier, send a first/second entity-related response to the at least one other device, receive, from the at least one other device, a first/second entity-related device response, and send, to the at least one other device, a first/second entity-related second peripheral response including the first/second entity-related peripheral device identifier.

Abstract: The present invention relates to a polymeric water repellent material including novel acrylamide polymer, which can be used in various field because it demonstrates controllable and excellent water repellency together with water adhesiveness. The polymeric water repellent material comprises an acrylamide polymer including at least one repeating unit.

Abstract: Disclosed is a system and method for recognizing a parking space line marking for a vehicle. In particular, a corner capturing process is configured to capture an angled corner in an image including the parking space line marking, and a cross capturing process is configured to capture a cross point by combining adjacent corners among the captured corners. A space capturing process captures a space which is an end periphery of the parking space line marking by combining the captured cross points. As a result of the above processes, a type selecting process can then select a type of the parking space line marking from the captured space, and a final selection process may select a final space based on the selected type.

Abstract: The present invention is directed to an insect attractant having an amount of methyl salicylate effective to attract a plurality of vectors of citrus greening disease and an agriculturally acceptable carrier.

Abstract: A network (100) includes a hub device (110) and at least one unattached peripheral device (120). The hub device comprises circuitry and a transceiver in communication with the circuitry. In operation, the hub device is configured to cause the transceiver to i) send a message to indicate the availability of the hub device for attachment to a first peripheral device, ii) receive, from the first peripheral device, a message indicating the availability of the first peripheral device for communication with the hub device, iii) send, to the first peripheral device, a signal including a first peripheral device identifier, iv) receive, from the first peripheral device, a response, v) send a hub response to the first peripheral device, and vi) receive, from the first peripheral device, a second peripheral response including the first peripheral device identifier.

Abstract: Disclosed is a composition including camphene as an active ingredient for preventing or treating obesity, dyslipidemia, fatty liver or insulin resistance syndrome. The composition of the present disclosure including camphene as an active ingredient suppresses differentiation of adipocytes, reduces body fat, reduces visceral fat, reduces total cholesterol level, reduces serum triglyceride level and reduces liver tissue triglyceride level, and thus exhibits preventive or therapeutic activity for obesity, hyperlipidemia or fatty liver. Furthermore, the composition of the present disclosure exhibits the effect of improving type 2 diabetes or insulin resistance and related metabolic disease by significantly reducing fasting blood sugar level and blood insulin level.

Abstract: Methods for proteomic analysis are provided. For example, in one aspect a method for identifying and sequencing a peptide may include fractionating a biological sample containing a peptide of interest to at least partially isolate the peptide, obtaining mass spectra of the peptide, and accelerating the peptide into a collision chamber at a plurality of discrete collision energies for a discrete period of time to form a plurality of peptide fragments for each of the plurality of discrete collision energies.

Abstract: Systems and methods are provided for providing ventilation to a patient. An air source is configured to provide pressurized air to a patient through a patient circuit according to a ventilation pattern. At least one sensor is configured to monitor a corresponding physiologic property of the patient. A ventilator control system is configured to calculate an alveolar ventilation value from the monitored physiologic property of the patient, determine at least an optimal frequency for the ventilation pattern from the calculated alveolar ventilation value, and update the ventilation pattern according to the determined optimal frequency.

Abstract: A compact pipe specimen applicable to a fracture toughness test used to evaluate physical properties of a pipe material is provided. The compact pipe specimen includes: a pipe having a notch portion formed in a circumferential direction and a crack portion formed at the edge of the notch portion; and first and second jigs having openings to which a pressurizing unit is coupled so as to cause a bending load on the pipe, having the notch portion therebetween, and attached to the exterior surface of the pipe, respectively. It is unnecessary to correct the influence of a constraint effect due to varying sizes and shapes of the specimen. There is no restriction to the curvature and thickness of a pipe. A fracture behavior of a pipe crack portion can be precisely simulated.

Abstract: Disclosed is a method for producing an optically active 2-hydroxy ester, comprising selectively esterifying one enantiomer of a racemic 2-hydroxy ester in a solvent containing a catalyst such as tetramisole or benzotetramisole, and a carboxylic acid anhydride, or a carboxylic acid anhydride and a carboxylic acid. In particular, in the case where the solvent contains a carboxylic acid anhydride, but does not contain a carboxylic acid, as the carboxylic acid anhydride, a carboxylic acid anhydride containing a tertiary or quaternary carbon atom in the a-position is used. On the other hand, in the case where the solvent contains a carboxylic acid anhydride and a carboxylic acid, as the carboxylic acid, a carboxylic acid containing a tertiary or quaternary carbon atom in the a-position is used.

Abstract: The present invention relates to a use of Substance-P for the manufacture of a medicament for mobilization or proliferation of Mesenchymal stem cells (MSCs) from the bone marrow, or facilitating said mobilization or proliferation, and use of Substance-P for the manufacture of a medicament for wound-healing or facilitating wound-healing.

Abstract: A method for controlling a photovoltaic (PV) panel in a PV system including a computing device that provides motor control signals and implements an iterative adaptive control (IAC) algorithm for adjusting an angle of the PV panel. The IAC algorithm relates P at a current time k (P(k)), an elevation angle of the PV panel at k (?S (k)), P after a next step (P(k+1)) and an elevation angle of the PV panel at k+1 (?S (k+1)). The algorithm generates a perturbed power value P(k+1) to provide a power perturbation to P(k), and calculates ?S (k+1) using P(k+1). The motor control signals cause the motor to position the PV panel to achieve ?S (k+1). A change in P resulting from the positioning is compared to a predetermined change limit, and only if the change in P is ? the change limit, again sensing P, and repeating the generating, calculating and positioning.

Abstract: The present invention includes cold-adapted, acid-fast bacterium for use as a vaccine and a vaccine vector. In preferred embodiments, the cold-adapted, acid-fast bacterium is a Mycobacteria, for example, Mycobacteria shottsii.

Abstract: Provided are method of generating a fiber from a globular protein such as albumin. Also provided are albumin fibers and fabrics and methods of using same for bonding a damaged tissue or for ex vivo or in vivo formation of a tissue.

Abstract: The present invention relates to a method of making a powder from apple peel by providing an apple peel, subjecting the apple peel to a phytochemical preservation treatment, drying the treated apple peel, and grinding the dried, treated apple peel to a powder. A powder from apple peel having a phenolic content and a flavonoid content similar to fresh apple peel on a fresh weight basis, where the powder has a water activity of less than 0.30 is also disclosed. The present invention also relates to a method of treating cancer in a patient by administering a powder from apple peel to a patient under conditions effective to treat cancer. Also disclosed is a method of inhibiting proliferation of cancer cells by contacting cancer cells with a powder from apple peel under conditions effective to inhibit proliferation of the cancer cells.